Medicines and the New Economic Environment
(1998; 252 pages) [Spanish]
Table des matières
Afficher le documentTHE AUTHORS
Afficher le documentPREFACE
Afficher le documentINTRODUCTION
Ouvrir ce répertoire et afficher son contenuI. THE GLOBAL ECONOMIC ENVIRONMENT
Fermer ce répertoireII. THE REFORM OF HEALTH CARE SYSTEMS
Ouvrir ce répertoire et afficher son contenuII. 1. Cost Containment and Health care Reforms: the Impact on Pharmaceuticals
Ouvrir ce répertoire et afficher son contenuII.2. Reform of Health Care Services in Developing Countries, Role of the State and Essential Drugs
Fermer ce répertoireII.3. Regulation, Policies and Essential Drugs
Ouvrir ce répertoire et afficher son contenu1. TWO MAJOR TRENDS
Fermer ce répertoire2. DRUGS
Ouvrir ce répertoire et afficher son contenu2.1. The process of innovation
Ouvrir ce répertoire et afficher son contenu2.2. The selection process
Ouvrir ce répertoire et afficher son contenu2.3. The expansion of markets
Fermer ce répertoire2.4. The creation of common areas: harmonization
Afficher le document2.4.1. Harmonization of marketing authorization procedures
Afficher le document2.4.2. Harmonization of pharmacological standards
Afficher le document2.4.3. Harmonization of good manufacturing practices (GMPs)
Afficher le document2.4.4. Intellectual property
Ouvrir ce répertoire et afficher son contenu2.5. Ongoing processes
Afficher le document3. CONCLUSIONS
Ouvrir ce répertoire et afficher son contenuIII. A CHANGING PHARMACEUTICAL INDUSTRY
Ouvrir ce répertoire et afficher son contenuIV. SYNTHESIS AND FORECASTS
Afficher le documentBIBLIOTECA CIVITAS ECONOMÍA Y EMPRESA
Afficher le documentBACK COVER
 
2.4.3. Harmonization of good manufacturing practices (GMPs)

According to the new global concept of quality which prevails today in the industrial world, the process of harmonization of the standards referring to quality assurance of the product is clearly aimed at creating basic manufacturing regulations. A global control over the quality of the manufacturing process would involve the maximum guarantee of producing a good final product.

This is why today, the basic requirement to allow the import of a pharmaceutical product is to demand clear evidence that manufacturing has been carried out in accordance with Good Manufacturing Practices standards. Consequently, all processes for trade harmonization aim to guarantee that all associates agree that they would apply the same Good Manufacturing Practice standards.

As a conclusion to this, a process for the harmonization of a manufacturing sites inspection system, through which adherence to GMP may be verified, should be implemented. As it will be seen later, this will be the basis of the WHO Quality Certificates for products under international trade.

GMP regulations neither dispute nor compete with the international efforts towards general quality harmonization which takes place based on the ISO systems, especially the 9000 series. GMPs are simply a specific development of quality assurance systems, within a specific production sector, with highly singular characteristics.

vers la section précédente vers la section suivante
 

Dernière mise à jour: le 3 mai 2013